The $59.4m round will support the development of four clinical-stage candidates for neurological disorders Noema licensed from shareholder Roche.

The gene-editing drug developer has completed its first publicly announced round, with Alphabet unit GV the only disclosed participant.

The Croda International-backed biopharmaceutical developer has cloesd a $13.2m round to boost its overall funding to about $25m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Existing backers including Draper Esprit and Sussex Place Ventures have reinvested to bring Endomag’s overall funding to above $43m.

The immuno-ocology startup has completed a series A round backed by Merck & Co investment vehicle MRL Ventures Fund.

Legend Capital returned as Xbiome secured an eight-digit dollar amount that wil support the progress of its microbiome drug pipeline.

The dental aligner provider closed a Ping An-backed series C round earlier this year but has now collected more funding in a Cadence Growth Capital-led round.

Haier Biomedical led a $15.2m round for the medical device maintenance service that also featured Zhejiang Orient Financial Holdings and Legend Capital.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.